These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

853 related items for PubMed ID: 22152935

  • 1. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F.
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [Abstract] [Full Text] [Related]

  • 2. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN, Couturaud F.
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [Abstract] [Full Text] [Related]

  • 3. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
    Couturaud F, Kearon C.
    Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
    [Abstract] [Full Text] [Related]

  • 4. Venous thromboembolism: risk factors for recurrence.
    Zhu T, Martinez I, Emmerich J.
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [Abstract] [Full Text] [Related]

  • 5. What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.
    East AT, Wakefield TW.
    Semin Vasc Surg; 2010 Sep; 23(3):182-91. PubMed ID: 20826296
    [Abstract] [Full Text] [Related]

  • 6. Long-term management of patients after venous thromboembolism.
    Kearon C.
    Circulation; 2004 Aug 31; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
    [Abstract] [Full Text] [Related]

  • 7. Evaluation and management of chronic pulmonary thromboembolic disease.
    Mendoza V, Scharf ML.
    Hosp Pract (1995); 2011 Aug 31; 39(3):50-61. PubMed ID: 21881392
    [Abstract] [Full Text] [Related]

  • 8. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
    Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Lärfars G, Leijd B, Linder O, Loogna E.
    N Engl J Med; 1997 Feb 06; 336(6):393-8. PubMed ID: 9010144
    [Abstract] [Full Text] [Related]

  • 9. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May 06; 22(138):129-33. PubMed ID: 23819181
    [Abstract] [Full Text] [Related]

  • 10. Treatment of deep vein thrombosis.
    Couturaud F, Kearon C.
    Semin Vasc Med; 2001 May 06; 1(1):43-54. PubMed ID: 15199513
    [Abstract] [Full Text] [Related]

  • 11. Medical therapy in venous thromboembolism.
    Eichinger S, Kyrle PA.
    Semin Respir Crit Care Med; 2012 Apr 06; 33(2):186-90. PubMed ID: 22648491
    [Abstract] [Full Text] [Related]

  • 12. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B, Palareti G.
    Semin Vasc Med; 2003 Aug 06; 3(3):303-14. PubMed ID: 15199464
    [Abstract] [Full Text] [Related]

  • 13. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS.
    Saudi Med J; 2004 Jul 06; 25(7):848-51. PubMed ID: 15235686
    [Abstract] [Full Text] [Related]

  • 14. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P, Barbar S, Milan M, Campello E, Spiezia L, Piovella C, Pesavento R.
    Thromb Haemost; 2015 Jun 06; 113(6):1210-5. PubMed ID: 25119194
    [Abstract] [Full Text] [Related]

  • 15. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
    Schulman S, Lindmarker P.
    N Engl J Med; 2000 Jun 29; 342(26):1953-8. PubMed ID: 10874063
    [Abstract] [Full Text] [Related]

  • 16. [Risk factors for recurrent venous thromboembolism].
    Rosencher J, Mirault T, Martinez I, Zhu T, Messas E, Emmerich J.
    Rev Mal Respir; 2011 Apr 29; 28(4):453-62. PubMed ID: 21549901
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M, Desruennes E, Di Palma M.
    Bull Cancer; 2006 Mar 01; 93(3):271-81. PubMed ID: 16567314
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.